Related Experiment Video
Updated: May 17, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines
Ilkka S Junttila1, Remi J Creusot, Ignacio Moraga
1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Nature Chemical Biology
|October 30, 2012
Summary
Engineered interleukin-4 (IL-4) variants, termed superkines, selectively target specific receptor chains. This cytokine engineering enhances potency and offers potential for targeted cytokine therapies by exploiting variable receptor chain expression.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Cytokine signaling relies on receptor dimerization, with a second receptor chain often initiating downstream effects.
- The interleukin-4 (IL-4) and IL-13 system utilizes distinct type I and type II receptor complexes, formed by alternative second receptor chains (common gamma chain [γc] or IL-13 receptor alpha 1 [IL-13Rα1]).
- Cellular expression levels of these second receptor chains vary, influencing the functional outcomes of IL-4 and IL-13 stimulation.
Purpose of the Study:
- To engineer human IL-4 variants with altered affinity and specificity for its second receptor chains.
- To investigate the impact of these engineered IL-4 variants on receptor complex formation and cellular signaling.
- To explore the potential of manipulating cytokine-receptor interactions for improved therapeutic selectivity.
Main Methods:
- Protein engineering of human IL-4 to create variants with enhanced affinity for either γc or IL-13Rα1.
- Assessing the potency of wild-type IL-4 and engineered superkines on cells expressing different type I and type II receptor compositions.
- Comparative transcriptional profiling to analyze gene expression changes induced by superkines versus wild-type IL-4.
- Investigating the role of the type II receptor in dendritic cell differentiation from monocytes.
Main Results:
- An IL-4 superkine with 3,700-fold increased affinity for γc demonstrated 3- to 10-fold higher potency than wild-type IL-4 for type I receptor signaling.
- An IL-4 variant with high affinity for IL-13Rα1 showed increased potency in activating type II receptor-expressing cells.
- This IL-13Rα1-binding superkine induced differentiation of dendritic cells from monocytes, suggesting a role for the type II receptor in this process.
- Superkines exhibited signaling advantages on cells with lower numbers of second receptor chains.
- Transcriptional analysis revealed largely overlapping gene expression profiles between superkines and wild-type IL-4.
Conclusions:
- Engineered IL-4 superkines can be designed to selectively target specific receptor chains, enhancing potency and potentially altering biological functions.
- Variable expression of second receptor chains can be leveraged to redirect cytokine action towards specific cell subsets.
- This approach offers a promising strategy for developing more selective and effective cytokine-based therapies.
- The type II receptor complex appears to play a role in monocyte-derived dendritic cell differentiation.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...